1. Home
  2. MYGN vs UHT Comparison

MYGN vs UHT Comparison

Compare MYGN & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.44

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

UHT

Universal Health Realty Income Trust

N/A

Current Price

$37.46

Market Cap

525.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
UHT
Founded
1991
1986
Country
United States
United States
Employees
2700
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
523.7M
525.1M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
MYGN
UHT
Price
$5.44
$37.46
Analyst Decision
Hold
Analyst Count
9
0
Target Price
★ $5.90
N/A
AVG Volume (30 Days)
★ 1.7M
90.4K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
★ 8.07%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.14
Revenue
★ $771,400,000.00
$99,190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.18
P/E Ratio
★ N/A
$32.61
Revenue Growth
★ 2.33
0.18
52 Week Low
$2.74
$36.07
52 Week High
$8.09
$46.30

Technical Indicators

Market Signals
Indicator
MYGN
UHT
Relative Strength Index (RSI) 46.99 41.45
Support Level $4.19 $36.30
Resistance Level $5.52 $39.45
Average True Range (ATR) 0.30 0.91
MACD -0.13 -0.14
Stochastic Oscillator 0.00 20.98

Price Performance

Historical Comparison
MYGN
UHT

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

Share on Social Networks: